# Study of KRN951 in Patients With Solid Tumors

> **NCT00970411** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** KRN951

## Key facts

- **NCT ID:** NCT00970411
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2017-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970411, "Study of KRN951 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00970411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*